跳至主要内容
临床试验/ACTRN12624000938505
ACTRN12624000938505尚未招募Unknown

Randomized study evaluating effects of rationalizing medication in those who have stunning of the heart due to a heart attack

Auckland City Hospital0 个研究点目标入组 90 人开始时间: 2024年8月2日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
19 Years 至 o limit(—)
性别
All

入选标准

  • 1.Age >18 years of age
  • 2.Able to give informed consent
  • 3.LVEF <40% post type 1 AMI who have recovered to >50% at week 2 echo
  • 4.Revascularised by percutaneous coronary intervention (PCI) during admission

排除标准

  • 1.previous known cardiomyopathy
  • 2.Atrial fibrillation
  • 3.Clinical heart failure at time of MI or since discharge
  • 4.Significant mitral or aortic valve disease
  • 5.Planned staged percutaneous intervention (PCI)/coronary artery bypass graft (CABG)
  • 6.LVEF>41% at baseline echocardiogram
  • 7.LVEF<50% at 2-week echocardiogram

研究者

相似试验